FDA verbally notified the company of additional questions in the application for the planned Phase I/II trial of HST-003 combined with microfracture.

ViBone Moldable, provided by Aziyo Biologics, is a next-generation viable cell bone matrix optimized to protect and preserve the health of native bone cells.

ALLOB will be applied by a single injection up to 4 days post-reduction surgery in patients with fresh tibial fractures at risk for delayed or non-union.

ReNu comprises amniotic fluid cells and micronized amniotic membrane, and contains cellular, growth factor and extracellular matrix components.

Expanded coverage includes treatment of symptomatic full-thickness cartilage defects in the patella and multiple cartilage defects in the knee.

Locate Bio developed CognitOss resorbable antibiotic-loaded bone graft to treat osteomyelitis.

This demineralized bone fiber form is designed for minimal access delivery into expandable cages, revisions and other surgical applications.

In 1H21, the company will launch FusePure Demineralized Bone Matrix, Strips and Cubes, and FuseTrilogy Viable Bone Matrix.

The transaction includes GUIDOR bone graft substitutes known as easy-graft and calc-i-oss, and builds on the company's strategy to expand its technologies.

The company has completed recruitment and treated all patients in its Phase III study with the viscosupplement, JTA-004, in patients with knee osteoarthritis.